The following biotechnology firms are involved in regenerative or neuroregenerative research.  Feel free to visit the links.  These links are either their web site or, in the absence of finding a web presence, contact information found in the National Biotech Registry or the Short Index of Biotechnology Companies on the web.
 

 A company that was set up by top neuroscientists to raise funds for clinical trials of therapies for spinal chord injuries.  Most biotech firms are less interested in funding such research because there are few spinal injuries per year and thus there is a small market for such medical treatments.

This company is devoted to developing memory-enhancing agents.  One accelerates the rate of neuron firing and consequent memory traces by binding glutamate -like molecules called ampakines to an NMDA receptor that controls such firing.
 

Using neurotrophic factors to help regenerate nerve tissue especially that of the spinal chord has been an ongoing project for Regeneron.  The company is also currently applying the study of such regulatory proteins to other clinical conditions as well since trophic factors can be implementing in reversing many kinds of tissue damage.

A memory-enhancement company that uses molecular biology to discover molecular signals that boost recall. As stated in the registry information "NeuroTherapeutics is a startup drug development company using antibody engineering technologies to develop peptides, peptoids and mimetics acting on CNS membrane receptors."

Cephalon, Inc. is "an international biopharmaceutical company dedicated to the
discovery, development and marketing of innovative products to treat neurological disorders."

These two companies as partners  are studying neurotrophic factors that regulate neurological functioning that can diminish with age.  The goal is also to cure neurological disorders such as Alzheimer's, Parkinson's, ALS, Huntington's diseases and age-related memory loss as well as stroke.
 

Other important biotech firms include Amgen, Biogen, Roche and Synergen.

 

Roslin Institute Online

The home page of this institute which focuses on the benefits of cloning farm animals. It also does other genetic and genomic research as well.
 

Karolinska Institute

This institute has made the remarkable breakthrough of causing the neuroregeneration of a rat's severed spinal chord. The 0.2 inch gap was connected by a neural bridge from chest neurons which provided a substratum along which the spinal axons could migrate. This is precisely what is the primary goal for clinical application in humans due to car accidents, gun shot wounds, sports injuries etc. that paralyze so many each year. It also will allow for human cloning and later head transplantation into the recipient clonal body.
 
 

Neuroregeneration Center

A center with headquarters in Puerto Rico that is becoming a leading research institute in neuroregeneration
 

Neurotransplantation Research Laboratory at Harvard University

A link to research using fetal tissue for increasing neuroregeneration and neuroplasticity including a video of transplantation of fetal pigs cells to humans patients. A link within it goes to the Harvard Neurosurgery Page which has a multitude of links to various neuro-centers associated with Harvard and its Medical School.

American Paralysis Association Affiliates: Christopher Reeve Foundation, Kent Waldrep National Paralysis Foundation,  Stifel Paralysis Research Foundation

Cure Paralysis Now

Someday Equestrian Designs

Note in re: cf.  Many recent developments in cloning such as of stem cells (11-12-98) are very closely related to both tissue regeneration/organogenesis and use gene therapy techniques.  (Such gene therapy techniques increasingly rely on genomic research as well.) Instead of listing this news separetely on three (or four)  pages, it has been posted to the gene therapy section of this web site.

 Return to table of contents.

E-mail me.